Global Dengue Testing Market 2022: Covering Historic Growth of Market and Forecasting the Future 2025

 Dengue Testing Market 2022

Government tendering and partnerships between diagnostic kit manufacturers are expected to provide long-term opportunities to the manufacturers in the dengue testing market. Governments in countries of Latin America and Asia Pacific are laying emphasis to eradicate diseases that have a higher infection rate by providing free diagnosis tests and medication to the underprivileged with the help of various government-funded programs. However, in order to achieve these objectives, the local authorities need a constant supply of related diagnostic kits. Governments rely on tendering or partnerships with manufacturers for delivering the required kits. Such kind of mechanisms also provide a stable financial flow to the manufacturers for a particular period.

Get Free Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/22738

These are some of the important findings of the latest report released by Persistence Market Research which is titled as ‘Dengue Testing Market: Global Industry Analysis 2012–2016 and Forecast 2017 – 2025’. Besides the qualitative analysis on the market dynamics operating in the global dengue testing market, the report also features a comprehensive quantitative assessment of the various segments and regions that are prominent in this market. As per the numbers that are given in this report, the global dengue testing market was valued at US$ 451.6 Mn in 2017 and is forecasted to reach a valuation of US$ 739.4 Mn in 2025, displaying a CAGR of 6.4% during the period of assessment 2017-2025.

Company Profiles:

• Abnova Corporation
• Roche Molecular Systems Inc.
• Abbott Laboratories
• InBios International, Inc.
• NovaTec Immundiagnostica GmbH
• Euroimmun AG (Sub. PerkinElmer)
• Quest Diagnostics
• Certest Biotec S.L.
• OriGene Technologies
• Thermo Fisher Scientific Inc.
• Others.

Request for Methodology@ https://www.persistencemarketresearch.com/methodology/22738

Global Dengue Testing Market: Dynamics

To control the spread of dengue fever, reduce the number of deaths and prevent its reoccurrence in the future, governments across the world have adopted various comprehensive dengue control policies that basically focus on prevention and cure. The multi-pronged efforts for dengue control include provision of diagnosis and treatment facilities for dengue fever at all the health centers and adoption of preventive measures. Various countries have set up their own national programs such as the National Dengue Prevention and Control Program in countries such as Indonesia, Brazil, India and Philippines. The World Mosquito Program, formerly known as Eliminate Dengue is helping to protect the global population from mosquito-borne diseases. Such type of interventions are boosting the global dengue testing market all over the world.

However, despite the high level of awareness for dengue prevention and cure, there are various challenges such as inadequate funding and resources and a lack of sound strategy to respond to the increasing problems related to dengue outbreaks in various regions of the world. Rapid urbanization, lack of sanitation, increase in international trade and mobility of population restraint the efforts to control dengue. In addition, lack of well-organized dengue control programs in collaboration with different sectors and agencies also restraints the market growth of dengue testing.

Access Full Report@ https://www.persistencemarketresearch.com/checkout/22738

Global Dengue Testing Market: Segmentation and Forecast

The global dengue testing market is segmented on the basis of product type, end-user and region.

• ELISA based tests segment accounted for 46.6% share in 2016 and is projected to account for 46.5% share by 2025 end in the global dengue testing market.
• The hospitals segment was valued at US$ 196.9 Mn in 2017 and is projected to reach a valuation of US$ 334.4 Mn in 2025, registering a CAGR of 6.8% during the period of assessment.
• Middle East and Africa dengue testing market was valued at US$ 139.7 Mn in 2017.

About Us: 

PersistenceMarketResearch is an esteemed company with a reputation of serving clients across domains of information technology (IT), healthcare, and chemicals. Our analysts undertake painstaking primary and secondary research to provide a seamless report with a 360 degree perspective. Data is compared against rep/uted organizations, trustworthy databases, and international surveys for producing impeccable reports backed with graphical and statistical information.

Contact Us:

Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com

 

Perineal Care Market 2022 – 2025: Business Trends, Global Segments, Size, Share, Industry Profit Growth, Regional Study and Emerging Technologies

 Perineal Care Market 2022

Persistence Market Research (PMR) has published a new research report on perineal care titled “Perineal Care Market: Global Industry Analysis 2012 – 2016 and Forecast 2017 – 2025.” The perineal care market is anticipated to grow significantly due to rise in increasing prevalence of urinary incontinence and fecal incontinence or double incontinence disorders, which make patients susceptible to incontinence associated dermatitis, in turn driving the demand for perineal care products.

Companies are likely to focus on the production of high volume low margin products as it has been observed that 50% of the elderly population above the age of 65 years suffer from incontinence. This age group is also the most probable to be struggling with inadequate or stable earnings from pensions, making the necessity for an inexpensive continence care product that much greater.

Get Free Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/13438

According to the report, the global perineal care market is expected to register a CAGR of 4.6% from 2017 to 2025. In 2017, the marker was worth US$ 878.2 Mn and it is expected to reach a valuation of US$ 1,254.8 Mn by the end of 2025.

Company Profiles:

• 3M Company
• Coloplast A/S
• Smith and Nephew plc.
• ConvaTec Group plc.
• Essity Aktiebolag (SCA Hygiene AB)
• Cardinal Health, Inc.
• Sage Products, LLC (Stryker Corporation)
• GOJO Industries, Inc.
• Medline Industries, Inc.
• Others.

Request for Methodology@ https://www.persistencemarketresearch.com/methodology/13438

Rising Use of Hygiene Products to be Observed Across the Globe

Consumption of perineal care products is growing significantly, supported by increase disposable income across both developing and developed economies. A significant change has been observed in the lower and middle income countries in terms of living standards, disposable income and urbanization. Consumption of hygiene products has increased significantly in countries such as Japan, China, and Brazil over the last decade and the trend is expected to continue in the near future. Growing awareness among physicians and patients regarding the benefits of perineal care products is expected to boost demand over the forecast period. Players in the market are focusing on increasing awareness about incontinence products through various apps and awareness campaigns.

For instance, Commonwealth of Australia provides continence care management services for patients advised by healthcare professionals to obtain a full assessment of bladder-related problems. This organization also provides a dedicated continence helpline, through which one can get expert advice about continence products. In 2014, the SCA launched a new mobile app called the TENA Recommender to support caregivers looking after their loved ones suffering from incontinence, who are not very familiar with incontinence care products.

Access Full Report@ https://www.persistencemarketresearch.com/checkout/13438

Reluctance to Buy Perineal Care Products to Hinder Market Growth

Bladder control and capacity tends to decrease with increasing age and rising frequency of urination and can lead to incontinence problems that most of the people are reluctant to discuss with doctors. Psychological barriers may hamper the demand for disposable products to a certain extent. According a study conducted by the U.S department of Health and Human Services, around 26 million people in the U.S. suffer from urinary incontinence; of these 60% are reluctant to discuss their problem with physicians, which leads to a decrease in the consumption of disposable incontinence products.

About us: 

Hip Replacement, Hip Replacement Market, Hip Replacement Market Size, Hip Replacement Market Share, Hip Replacement Market, Hip Replacement Market overview, PersistenceMarketResearch, Hip Replacement Market Growth, Hip Replacement Market Analysis, Hip Replacement Market Demand, Hip Replacement Market Forecast, Hip Replacement Market Survey

Contact us:

Persistence Market Research          
Address – 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com

Perineal Care Market, Growth, Trends, Analysis, Opportunities and Forecast To 2025

 Perineal Care Market 2022

Persistence Market Research (PMR) has published a new research report on perineal care titled “Perineal Care Market: Global Industry Analysis 2012 – 2016 and Forecast 2017 – 2025.” The perineal care market is anticipated to grow significantly due to rise in increasing prevalence of urinary incontinence and fecal incontinence or double incontinence disorders, which make patients susceptible to incontinence associated dermatitis, in turn driving the demand for perineal care products.

Companies are likely to focus on the production of high volume low margin products as it has been observed that 50% of the elderly population above the age of 65 years suffer from incontinence. This age group is also the most probable to be struggling with inadequate or stable earnings from pensions, making the necessity for an inexpensive continence care product that much greater.

Get Free Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/13438

According to the report, the global perineal care market is expected to register a CAGR of 4.6% from 2017 to 2025. In 2017, the marker was worth US$ 878.2 Mn and it is expected to reach a valuation of US$ 1,254.8 Mn by the end of 2025.

Company Profiles:

• 3M Company
• Coloplast A/S
• Smith and Nephew plc.
• ConvaTec Group plc.
• Essity Aktiebolag (SCA Hygiene AB)
• Cardinal Health, Inc.
• Sage Products, LLC (Stryker Corporation)
• GOJO Industries, Inc.
• Medline Industries, Inc.
• Others.

Request for Methodology@ https://www.persistencemarketresearch.com/methodology/13438

Rising Use of Hygiene Products to be Observed Across the Globe

Consumption of perineal care products is growing significantly, supported by increase disposable income across both developing and developed economies. A significant change has been observed in the lower and middle income countries in terms of living standards, disposable income and urbanization. Consumption of hygiene products has increased significantly in countries such as Japan, China, and Brazil over the last decade and the trend is expected to continue in the near future. Growing awareness among physicians and patients regarding the benefits of perineal care products is expected to boost demand over the forecast period. Players in the market are focusing on increasing awareness about incontinence products through various apps and awareness campaigns.

For instance, Commonwealth of Australia provides continence care management services for patients advised by healthcare professionals to obtain a full assessment of bladder-related problems. This organization also provides a dedicated continence helpline, through which one can get expert advice about continence products. In 2014, the SCA launched a new mobile app called the TENA Recommender to support caregivers looking after their loved ones suffering from incontinence, who are not very familiar with incontinence care products.

Access Full Report@ https://www.persistencemarketresearch.com/checkout/13438

Reluctance to Buy Perineal Care Products to Hinder Market Growth

Bladder control and capacity tends to decrease with increasing age and rising frequency of urination and can lead to incontinence problems that most of the people are reluctant to discuss with doctors. Psychological barriers may hamper the demand for disposable products to a certain extent. According a study conducted by the U.S department of Health and Human Services, around 26 million people in the U.S. suffer from urinary incontinence; of these 60% are reluctant to discuss their problem with physicians, which leads to a decrease in the consumption of disposable incontinence products.

About us: 

Hip Replacement, Hip Replacement Market, Hip Replacement Market Size, Hip Replacement Market Share, Hip Replacement Market, Hip Replacement Market overview, PersistenceMarketResearch, Hip Replacement Market Growth, Hip Replacement Market Analysis, Hip Replacement Market Demand, Hip Replacement Market Forecast, Hip Replacement Market Survey

Contact us:

Persistence Market Research          
Address – 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com

Hearing Aids Market by Component, Application, Growth and Analysis – 2031

 Hearing Aids Market 2022

The increasing prevalence of hearing loss, growing geriatric population, and continuous research & development for innovative hearing aids are some of the factors that will drive the global market at a CAGR of 5.2% to reach US$ 12.9 Bn by 2031. Furthermore, government support & assistance in procuring hearing aids and growing awareness about hearing devices and implants are also other demanding factors adding to market expansion.

Get Free Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/4414

Demand for hearing aids is also increasing with the decrease in cost, thus providing access to a larger population. The predominant cause price drop is increasing number of emerging players in the market. Hearing technology today offers better hearing aids with advanced features and functionality. Reduction of wind noise is one of the major features incorporated by hearing aids manufacturers. Also, manufacturers are focusing on launching hearing aids with advanced software (smart hearing aids) to help users program these aids according to their needs.

• For instance, in January 2020, Phonak (Sonova) introduced the next generation aid- Phonak Naida Marvel, which can be connected directly to Android or iOS smartphones and other Bluetooth devices. Also, users can enjoy hands-free calls, TV, music, e-books, and podcasts.
• Livio Edge AI (Starkey), Phonak Audèo paradise (Sonova), Oticon More (Oticon, Inc.), ReSound LiNx Quattro (GN Group), and MOMENT RIC 10 (WS Audiology A/S) are some of the commercially available smart hearing aids in the market.

Company Profiles:

• Audina Hearing Instruments, Inc.
• Audina Hearing Instruments, Inc.
• Starkey Laboratories, Inc.
• Demant A/S
• BHM-Tech Produktionsgesellschaft GmbH
• GN Hearing
• Microson
• Sonova Holding AG
• WS Audiology A/S
• Eargo Inc.

Request for Methodology@ https://www.persistencemarketresearch.com/methodology/4414

Key Takeaways from Market Study

• Behind-The-Ear (BTE) hearing aids are patient/user-friendly, have easy maintenance, low cost, and a better fit, which makes this the highest shareholder with 82.3% market share in 2021.
• Digital hearing aids is a leading segment by technology, accounting for 98.9% of the global market share in 2021.
• Audiology clinics are expanding at a pace way faster than ENT clinics or online stores, and are expected to hold nearly 50% of the global market share.
• With increasing hearing loss prevalence, large number of key players’ presence, and technological advancements, North America and Europe together hold a market share of more than 70% in the global market.

“Increasing prevalence of hearing impairment, favourable reimbursement policies, and introduction of technologically advanced hearing aids are expected to drive market growth over the decade,” says an analyst of Persistence Market Research.

Access Full Report@ https://www.persistencemarketresearch.com/checkout/4414

Market Competition

Oticon Inc., in January 2021, introduced Oticon More, the first-ever hearing aid with an on-board deep neural network (DNN) to provide patients with mild-to-severe hearing loss with a more complete, balanced, and effortless listening experience.

Similarly, Starkey, in February 2020, introduced the first AI-enabled hearing aid- Livio Edge AI. With a simple double tap, Edge Mode brings the power of artificial intelligence to one’s fingertips.

Key manufacturers of hearing aids are thus contributing highly to market growth by introducing new and novel products by gaining FDA approval, in order to improve their presence in the market and gain a significant market share.

What Does the Report Cover?

Persistence Market Research offers a unique perspective and actionable insights on the hearing aids market in its latest study, presenting historical demand assessment of 2016 – 2020 and projections for 2021 – 2031.

The research study is based on product (behind-the-ear (BTE) hearing aids, receiver-in-the-ear (RIE) hearing aids, in-the-ear (ITE) hearing aids, in-the canal (ITC hearing aids), and completely-in-the canal (CIC) hearing aids), technology (conventional hearing aids and digital hearing aids), and end user (audiology clinics, ENT clinics, and online stores), across seven key regions of the world.

About us: 

PersistenceMarketResearch is an esteemed company with a reputation of serving clients across domains of information technology (IT), healthcare, and chemicals. Our analysts undertake painstaking primary and secondary research to provide a seamless report with a 360 degree perspective. Data is compared against rep/uted organizations, trustworthy databases, and international surveys for producing impeccable reports backed with graphical and statistical information.

Contact us:

Persistence Market Research          
Address – 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com

 

DNA Sequencing Market 2022 Global Analysis, Opportunities and Forecast To 2026

 DNA Sequencing Market 2022

DNA sequencing is a laboratory technique used to determine the sequence of a DNA molecule. Particularly, the arrangement of four nucleotide bases i.e. Guanine, Cytosine, Adenine, and Thymine can be identified by usage of various sequencing techniques available in the market. Human Genome Project was the major step in this direction for analyzing the complete human genome sequence.

Nowadays, the usage of DNA sequencing techniques has increased with several applications available in the field of medicines, agriculture, forensics, biological research, and others. Starting from Sanger sequencing, the market is growing with significant pace with millions of sequencing analysis going done per day. This is all due to the technological expansion in this field which improves the speed, accuracy, fidelity and magnitude of sequencing methods.

Next generation sequencing is the latest technology in the field of sequencing. Some of the leading NGS platforms products available commercially includes Illumina (Solexa), Roche 454, Ion Torrent and SOLiD sequencing. Latest, third-generation DNA sequencing machines such as SMRT and Oxford Nanopore are available in the market which measures the real time addition of nucleotides to a single DNA molecule.

Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/14122

Oncology research is the key application area for DNA sequencing which is increasing the usage of sequencing techniques to detect the mutations. Key, Next Generation DNA Sequencing market players, includes Life Technologies, Illumina, Hamilton Thorne Biosciences, Siemens AG, Pacific Biosciences, Eppendorf, Perkin Elmer, Tecan, and Thermo Scientific with different sequencer machine models.

Personal genomics and personalized medicines are becoming the future of healthcare and treatment. In addition to this, the future is also moving towards digital DNA data storage which is going to increase the use of DNA sequencing and innovation.

The increasing trends of personalized genomics, growing demand for easy and fast clinical diagnosis, increase in the cancer research activities, high throughput technology, funding by the governmental agencies for research activities and landing up of various leading companies in DNA sequencing is expected drive the growth of DNA sequencing market.

However, expensive machinery, algorithmic challenges, repeat content, professional expertise and ethical issues are some of the challenges that restraints the market of DNA sequencing from growing.

Request for Table of Content@ https://www.persistencemarketresearch.com/toc/14122

DNA Sequencing Market: Segmentation  

By Applications	Forensics Research Diagnostics Treatment analysis Personalized genomics
By End User	Contract Research Organizations Academic Institutions Pharmaceutical Industries Hospitals Diagnostic centres
By Techniques:	Ion semiconductor sequencing Pyrosequencing SBS (Sequencing by Synthesis) Technology Sequencing by Ligation Single molecule real time sequencing (SMRT) Chain Termination Sequencing Nanopore Sequencing
By Geography	North America Europe Latin America APEJ Japan MEA

Access Full Report@ https://www.persistencemarketresearch.com/checkout/14122

Based on geography, DNA Sequencing market is segmented into five key regions: North America, Latin America, Europe, Asia-Pacific and the Middle East & Africa. North America is at the top in the use of high-throughput sequencers owing to availability of skilled professionals and growing innovation in the sequencing technology.

Europe is at its second position in overall DNA sequencing market share with growing focus on cancer research by CROs and biopharmaceutical companies. Asia-Pacific is expected to grow in the future because of the increasing government funds in the research sector. Some of the key market players in the DNA sequencing market are Siemens AG, Pacific Biosciences, Eppendorf, Perkin Elmer, Agilent Technologies Inc., Illumina, Genia Corporation, Oxford Nanopore technologies, Roche Holdings AG, ThermoFisher Scientific and many others.

About us: Persistence Market Research

Contact us:

Persistence Market Research          
Address – 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com

 

 

Meningococcal Vaccines Market Key Players, Size, Share, Analysis and Forecast To 2026

 Meningococcal Vaccines Market 2022

The meningococcal vaccine market has expanded to a significant extent over the past few years in correspondence to the parent market. Constant research and development in meningococcal vaccines for various meningococcal disease preventive applications, coupled with the sanctions of subsidy & support of government organizations for immunization program are among the significant factors that are anticipated to drive the growth of the meningococcal vaccine market during the forecast period.

Free Sample Copy Of Meningococcal Vaccines Market Report@ https://www.persistencemarketresearch.com/samples/3640

Expansion of the age group indication related to new sero-groups is boosting the potential population pool, thus boosting the market growth. As per the latest research by PMR, the global meningococcal vaccine market is estimated to account for ~ US$ 6.5 billion in terms of revenue by the end of 2029. The meningococcal vaccine market report also projects a significant growth prospective with a projected average Y-o-Y growth rate of ~ 10% during the forecast period.

Company Profiles: 

• Sanofi Pasteur Inc.
• GlaxoSmithKline
• Wyeth Pharmaceuticals

How About Revitalizing The Strategy-Oriented Funnel To Stay Ahead In The Meningococcal Vaccines Market? https://www.persistencemarketresearch.com/methodology/3640

Although many effective meningococcal vaccines have already been developed, persistent product gaps still remain. Creating stable meningococcal vaccine supply in developing countries provides significant growth opportunities for the manufacturers of meningococcal vaccines. To ensure stable supply, manufacturers must look for committed financing, high-quality manufacturing capacity, strong regulatory systems, and predictable demand. This also provides opportunities for local or regional players to partner with global players and stimulate procurement, as well as penetrate markets with high unmet needs.

Collaborations between multiple firms to evaluate and develop meningococcal vaccines and new supply and healthcare funding models are becoming progressively necessary to respond resourcefully to emergency outbreaks of infectious diseases such as meningococcal disease. Even after powerful competition in high-value vaccines markets, collaborations with emerging and developing countries is becoming complex, and the involvement of multiple manufacturers as well as private- and public-sector investments are essential for developing new resistive meningococcal vaccines against emerging infectious diseases.

Balanced Supply to Developed and Developing Regional Markets to Ensure Sustained Immunization

There is evidence that augmented demand for Gavi-aided meningococcal vaccines is encouraging the entry of a larger number of suppliers into the vaccine market. This is encouraging competition among players following the entry of new technologies into the market. Gavi’s support is based on a country’s ability to pay, as it intends to put countries on a trajectory toward financial sustainability. The co-financing commitments of a country increases its national income until it reaches a threshold. At the end of this process, countries are fully self-financing vaccines.

Every year, some countries are entering into an accelerated transition phase. For instance, 16 countries, which include Vietnam, Cuba, Angola, Indonesia, Bhutan, Honduras, Mongolia, Sri Lanka, etc., entered into a transition phase and reached the end of the full self-financing stage. This is expected to ensure equal immunization coverage across the globe and create growth opportunities in emerging meningococcal vaccine markets. The manufacturers of meningococcal vaccines are gradually focusing on value-driven services to boost their market penetration.

The addition of meningococcal vaccines to national immunization programs is expected to ensure the sustainable and affordable supply of these vaccines in the public as well as private sectors. This is estimated to accelerate the demand for meningococcal vaccines among the pediatric age group, thus contributing to meningococcal vaccine market growth. In addition, the expansion of the indication of certain meningococcal vaccines for use in certain age groups can be partially attributed to the growing consumption of meningococcal vaccine units across the globe.

For instance, in February 2018, the Ministry of Health, Government of Australia announced the upgradations of NIP to add Nimenrix-quadrivalent ACWY vaccines to the national immunization program of Australia. In July 2018, the Ministry of Health France declared that immunization with MenC vaccines is obligatory for all young children effective from 2018. Moreover, in 2014, single-dose meningococcal vaccine was added to the national immunization program of Pakistan.

PMR has segmented the global market for meningococcal vaccine based on product type, age group, distribution channel, and region. By product type, the market for meningococcal vaccine is further segmented into Serogroup B Meningococcal Vaccine (MenB-FHpb/MenB-4C), Meningococcal Conjugate Vaccine (MCV4) and Meningococcal Polysaccharide Vaccine (MPSV4). On the basis of age group, the meningococcal vaccine market is further segmented into Infants (0-24 months), Children, Adolescents and Young Adults, and Adults.

Go To “Purchase Now” To Have Our Meningococcal Vaccines Market Report@ https://www.persistencemarketresearch.com/checkout/3640

On the basis of distribution channel, the meningococcal vaccine market is segmented into Retail Sales and Institutional Sales. The institutional sales segment is further classified into Community Clinics, Public Health Agencies and Hospitals. By region, the meningococcal vaccine market is segment into Europe, Latin America, North America, South Asia, East Asia, Oceania, and the Middle East & Africa. The report tracks some of the major companies operating in the meningococcal vaccine market, which include GlaxoSmithKline Biologicals SA, Sanofi Pasteur SA, Wyeth Pharmaceuticals Inc. (a subsidiary of Pfizer Inc.), and Serum Institute of India Ltd.

About Us: 

PersistenceMarketResearch is an esteemed company with a reputation of serving clients across domains of information technology (IT), healthcare, and chemicals. Our analysts undertake painstaking primary and secondary research to provide a seamless report with a 360 degree perspective. Data is compared against rep/uted organizations, trustworthy databases, and international surveys for producing impeccable reports backed with graphical and statistical information.

Contact Us:

Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com

 

Immune Repertoire Sequencing Market by Size, Growth, Trends and Forecast – 2026

 Immune Repertoire Sequencing Market 2022

Persistence Market Research (PMR) delivers the key insights on the immune repertoire sequencing market in its upcoming report titled “Immune Repertoire Sequencing Market – Global Industry Analysis 2013 – 2017 and Forecast 2018 – 2026”. In terms of revenue, the immune repertoire sequencing market is projected to register a CAGR of 7.3% over the forecast period, owing to various factors, regarding which PMR offers detailed insights and forecasts in this report.

The immune repertoire sequencing market is segmented based on product type, application, end users and regions. Based on product type, the immune repertoire sequencing market is segmented into assay kits, software and services. The assay kits is expected to be the leading segment in the immune repertoire sequencing market and grow at a CAGR of 7.7% over the forecast period. Based on application, the immune repertoire sequencing market is segmented into cancer immunotherapy, infectious diseases, vaccine development and efficacy, transplant rejection & tolerance, autoimmune disease and biomarker discovery.

To remain ‘ahead’ of your competitors, request for a sample@ https://www.persistencemarketresearch.com/samples/14911

The cancer immunotherapy segment in the immune repertoire sequencing market is expected to account a high revenue share and grow at a CAGR of 8.7% over the forecast period. Based on end users, the immune repertoire sequencing market is segmented into academic institutes and research centres. The research centres is expected to be the leading segment in the immune repertoire sequencing market over the forecast period, growing at a CAGR of 7.6%.

Company Profiles:

• Illumina, Inc.
• Pacific Biosciences of California, Inc
• Agilent Technologies, Inc
• Oxford Nanopore Technologies, Ltd
• QIAGEN N.V.
• Thermo Fisher Scientific
• F. Hoffmann-La Roche Ltd
• BGI
• Takara Bio, Inc

For critical insights, request for methodology@ https://www.persistencemarketresearch.com/methodology/14911

The growth of the immune repertoire sequencing market is primarily driven by increasing prevalence of cancer and other infectious diseases and growing awareness for development of cell-mediated immunotherapies globally. In addition, other factors which is expected to propel the growth of the global Immune Repertoire Sequencing market include increase in healthcare expenditure, demand for genomic based research, increase in sequencing based projects, advancement in sequencing tools (pre-sequencing, bioinformatics solutions and cloud computing).

Besides, exceptional developments by China and Japan for integration of new technologies in biomedical research including advancement in genome sequencing is also expected to propel the growth of the immune repertoire sequencing market. The substantial price drop in high throughput sequencing is also expected to contribute to the growth of the immune repertoire sequencing market, particularly in underdeveloped countries of Latin America and MEA.

This report assesses the trends that are driving the growth of each segment of the immune repertoire sequencing market on the global as well as regional level, and offers potential takeaways that could prove substantially useful for the manufacturers planning to enter the immune repertoire sequencing market.

For in-depth competitive analysis, buy now@ https://www.persistencemarketresearch.com/checkout/14911

North America accounted a high revenue share in 2017, and is expected to be the dominant regional market for immune repertoire sequencing over the forecast period. The U.S. immune repertoire sequencing market is expected to hold a large share in North America and is expected to grow at a CAGR of 6.7% over the forecast period.

Large presence of globally renowned companies in high-throughput sequencing and increased scale of sequencing projects in the region is expected to increase the adoption of immune repertoire sequencing. Besides, the leading academic universities and research centers are based in North America, which is also expected to the surge the adoption of immune repertoire sequencing methods.

The Europe and Asia Pacific immune repertoire sequencing markets collectively will grow at CAGRs of 7.3% and 9.9 %, respectively, over the forecast period. The Latin America and Middle East and Africa immune repertoire sequencing markets are estimated to expand at CAGRs of 5.8% and 4.8%, respectively, over the forecast period.

Consistent investment in development of the healthcare sector in terms of research and services through governmental and private capital funding will drive the demand for immune repertoire sequencing in the region by implication of sequencing tools. High prevalence of infectious and other diseases is one of the key factors expected to drive the growth of the immune repertoire sequencing market in Middle East and Africa.

About us: Persistence Market Research

Contact us:

Persistence Market Research          
Address – 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com

 

Medical Gloves Market by Component, Application, Growth and Analysis – 2031

 Medical Gloves Market 2022

These products are available either in the powdered or in the non-powdered form or are powdered with cornstarch to lubricate them so that it becomes easier for one to put on. Before the usage of cornstarch, tissue irritating Lycopodium powder and talc was used. After which it was discovered that even cornstarch would impede healing especially during surgeries, hence non-powdered gloves were preferred during surgeries.

There are 2 types of medical gloves, exam gloves and surgical gloves. Surgical gloves, which are used during surgeries, are usually made to a higher standard and have more precise sizing, better precision and sensitivity, while exam gloves are available as either sterile glovers orf non-sterile gloves. Surgical gloves are always available as sterile gloves.

Get Free Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/4647

The key companies profiled for the manufacture of medical disposable gloves include Ansell Healthcare, Hartalega Holdings, Supermax Corporation Berhad, Kossan Rubber Products, Rubberex and Top Glove Corporation Bhd. among others.

These gloves have multiple purposes in the medical world right from surgical purposes to dental applications. These gloves are also used during commission of crimes due to their thinness and tight fit, which allows dexterity. Latex, which is used in the production of these gloves s being replaced by vinyl, nitrile rubber or neoprene, is widely used, as there is increasing rate of latex allergy among general population. Latex was used as a raw material as it was cheaper, the high grade nitrile gloves that are available nowadays is double the price of latex. This is one of the reasons, cost effective environments like hospitals have not replaced latex gloves yet.

The main factors that drive the medical drive market is the growing awareness of health and safety measures that have to be employed in order to stop spread of diseases. Patients and health medics have recognized the increasing need for gloves globally. Disposable gloves have served the medical industry for a long time in terms of hygiene maintenance, safety measures and low cost.

The non powdered glove market is expected to grow at a faster rate due to its use in surgery as compared to powdered gloves which retards the healing process. The healthcare and the medical industry is growing at a fast rate thus increasing the growth of disposable gloves market as it is the staple product required in this industry. However, the prices of raw materials keep fluctuating and currency fluctuations create complications for this market.

Request for Table of Content@ https://www.persistencemarketresearch.com/toc/4647

The key segments for the medical gloves industry include North America, Europe, Asia Pacific and Rest of the World (RoW). The U.S. is said to be largest market for disposable medical gloves while the Asia Pacific countries are known to be the fastest growing market in this sector. The developing healthcare industry is boosting the growth of these disposable gloves in the emerging countries.

The fast growth in the food processing, personal care, hygiene and medical industries are the major factors that enhance the growth of these gloves in North America. Europe follows North America concerning the usage of medical disposable gloves but the rapidly growing healthcare industry in developing countries is expected to increase thus decreasing the glove market share in Europe. These segments focus mainly on the production and manufacture of non-powdered gloves as the market for powdered gloves is decreasing owing to the fact that it retards the healing process.

Access Full Report@ https://www.persistencemarketresearch.com/checkout/4647

Medical Gloves Market – Report Highlights

• A detailed overview of parent market of Medical Gloves Market
• Changing Medical Gloves Market dynamics in the industry
• In-depth segmentation of the Medical Gloves Market
• Historical, current, and projected Medical Gloves Market size regarding volume and value
• Recent industry trends and developments in Medical Gloves Market
• Competitive landscape of the Medical Gloves Market
• Strategies for key players and products offered
• Potential and niche segments, geographical regions exhibiting promising growth
• A neutral perspective on Medical Gloves Market performance
• Must-have information for Medical Gloves Market players to sustain and enhance their market footprint

About Us: Persistence Market Research

Contact Us:

Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com

 

Smart Inhalers Market Global Industry Analysis, By Key Players Forecast to 2031

 Smart Inhalers Market 2022

This updated analysis on the smart inhalers market by Persistence Market Research predicts the industry to surge ahead at a CAGR of 23.5% and attain a net worth of US$ 1 Bn by the end of the decade.

Get Free Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/26881

Respiratory disorders such as asthma and COPD have become more frequent over the past decade, and this trend is expected to be followed through this decade as well. With more instances of respiratory issues being recorded, demand for treatment and therapies for these disorders has also subsequently risen.

Adoption of smart inhalers is expected to rise as more healthcare professionals recommend them and their efficiency in drug delivery and drug tracking is realized. Increased medical adherence, reduced costs of treatment, improved and better results, and ability to track and maintain a record of clinical data are some of the factors that are expected to propel the adoption of smart inhalers.

Key manufacturers of smart inhalers are investing in reaching out to untapped markets and are focusing on increasing product awareness. They are also adopting organic as well as inorganic strategies to boost sales across regions.

• In July 2019, Teva Pharmaceutical, a renowned pharmaceutical firm, announced that it has achieved FDA approval for its AirDuo Digihaler. The product is a sensor-enabled inhaler that sends usage data to a smartphone, and this information can also be shared with a medical provider.
• In May 2021, RYAH Medtech Inc. signed an agreement with exclusive product distribution and software development rights to its French partner, Delled SAS, for the RYAH smart inhaler.

Company Profiles:

• OPKO Health, Inc.
• AstraZeneca plc
• GlaxoSmithKline
• Propeller Health
• Aptar Pharma
• Novartis AG
• Boehringer Ingelheim
• Teva Pharmaceuticals
• H&T Presspart Manufacturing Ltd.
• Sensirion AG
• Cohero Health, Inc.
• Others.

Request for Methodology@ https://www.persistencemarketresearch.com/methodology/26881

Key Takeaways from Market Study

• The smart inhalers industry is predicted to expand at an impressive CAGR of 23.5% through 2031.
• The market in China is expected to rise at the fastest pace through 2031.
• Adoption of smart inhalers in North America is high and the market in this region accounts for a dominant share in the global landscape.
• Lack of awareness in underdeveloped economies is a major restraining factor for market growth.
• By 2031, the global smart inhalers market is predicted to be worth over US$ 1 Bn.
• Increased medical adherence, rising proliferation of technology in the medical industry, and growing awareness about the benefits of smart inhalers are some of the factors that favor market growth potential.

“To utilize the full revenue potential of the market, smart inhaler manufacturers would have to increase awareness and adoption of the product in developing regions,” says a Persistence Market Research analyst.

Competitive Landscape

The global market for smart inhalers has been identified as a fairly fragmented space due to the presence of a high number of market participants.

Some of the key market players included in the report are GlaxoSmithKline Plc., Teva Pharmaceutical Industries Ltd., Novartis AG, AstraZeneca plc, Boehringer Ingelheim International GmbH, Aptar Pharma (AptarGroup, Inc.), Propeller Health, OPKO Health Inc., H&T Presspart Manufacturing Ltd., Sensirion AG, and Cohero Health Inc.

The above are identified as key suppliers of smart inhalers. These market participants are engaged in market expansion activities and are focusing on mergers and collaborations to develop a better product portfolio and drive their sales funnel.

More Valuable Insights on Offer

Persistence Market Research, a research and consulting firm, has published a new market research report on the global smart inhalers market that contains industry analysis of 2016–2020 and opportunity assessment for 2021–2031.

The report provides an in-depth analysis of the market through different segments, namely, product type, disease indication, distribution channel, and region. The report also provides supply and demand trends along with an overview of the parent market.-

Access Full Report@ https://www.persistencemarketresearch.com/checkout/26881

Key Questions Answered in the Smart Inhalers Market Report

How is the Smart Inhalers market expected to grow over the projected period?

What direction is the Smart Inhalers market expected to take in terms of volume and value during the forecast period?

What is the impact of macroeconomic factors on the Smart Inhalers market in future?

What are the key market drivers in the Smart Inhalers market?

What are significant opportunities and improvement areas for Smart Inhalers manufacturers?

What are the key developments and trends taking over the Smart Inhalers market?

Which are the emerging countries that are expected to create significant growth opportunities in the Smart Inhalers market?

About Us: Persistence Market Research

Contact Us:

Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com

Endoscopic Mucosal Resection Market by Component, Application, Growth and Analysis – 2025

 Endoscopic Mucosal Resection Market 2022

An endoscopic technique called Endoscopic Mucosal Resection (EMR) is used for the resection of large distal colorectal poylps. EMR was developed for minimally invasive, organ sparing endoscopic removal of benign and early malignant lesions in the GI tract.

EMR is used to treat superficial neoplasms of the gastrointestinal tract. A new research report by Persistence Market Research is based on the analysis of the global endoscopic mucosal resection market and its overview. The report titled ‘Endoscopic Mucosal Resection Market: Global Industry Analysis 2012–2016 and Forecast 2017 – 2025’ includes the major aspects of the market such as the market size, growth rate, pricing analysis and much more.

Ask For Free Sample@ https://www.persistencemarketresearch.com/samples/13693

Company Profiles 

• Boston Scientific Corporation
• Cook Medical Inc
• Olympus
• Interscope, Inc.
• FUJIFILM Holdings Corporation
• CONMED Corporation
• STERIS Plc

Glance Through The “Methodology” Implied@ https://www.persistencemarketresearch.com/methodology/13693

According to the report forecast, the global endoscopic mucosal resection market reached a value of over US$ 1,400 Mn in 2017 and this is expected to increase to over US$ 2,500 Mn by the end of 2025. Revenue growth is anticipated to expand at a robust CAGR of 7.3% during the forecast period 2017-2025.

The growth is a result of new technological advancements in the global endoscopic mucosal resection market and companies are ready to make full use of this by launching new products in the market.

Global Endoscopic Mucosal Resection Market: Dynamics

The global endoscopic mucosal resection market has a major support of the macro factors like increase in the spending on healthcare sector in various regions by the local governments. This has led to an overall improvement in the technology used by the healthcare industry.

It has helped in increasing the number of endoscopic mucosal resection procedures worldwide. The market has also observed collaborations between the manufacturers. Original equipment manufacturers and third party service vendors focus on the collaboration and partnership activities in some regions to provide sales and after sales services effectively.

This boosts the brand image of endoscope reprocessing equipment and ultimately helps the growth of the global endoscopic mucosal resection market.

However, the global endoscopic mucosal resection market may face challenges in its growth due to stringent rules and regulations pertaining to the launch of new products in the market. Also, inadequate reimbursements of claims limits the willingness of people to spend on costly medical procedures like endoscopic mucosal resection.

Segmental Highlights from the Research Report

On the basis of region, Asia Pacific is expected to dominate the global market with the fastest growth rate of 7.9% during the forecast period. Another attractive region in the global endoscopic mucosal resection market is North America that is anticipated to hold the maximum market size by the end of 2025.

Click The “Purchase Now” Button Of Our Endoscopic Mucosal Resection Market Report@ https://www.persistencemarketresearch.com/checkout/13693

On the basis of technology, suck-and-cut technique is the most lucrative segment with a high CAGR, whereas the lift-and-cut technique leads with a higher market size during the forecast period.

On the basis of indication duodenal cancer and esophageal cancer are both attractive segments according to the analysis.

On the basis of end user, hospitals hold the maximum market size with an expected value of over US$ 1,400 Mn by the end of 2025.

About us: Persistence Market Research

Contact us:

Persistence Market Research          
Address – 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com

Endoscopic Submucosal Dissection Industry 2022 Global Key Players, Market Dynamics, Future Demand Analysis and Forecasts To 2031

 Endoscopic Submucosal Dissection Market 2022

The Global Endoscopic Submucosal Dissection Market is expected to grow at an unstoppable rate In Upcoming Years. With environmental health being a matter of concern, everything – right from public transport networks, power supply, and storage of waste to monitoring the ecological balance is being taken up by IoT and AI. It could, thus, be inferred that with “smart cities” would come “smart end-user solutions” in the years to come.

Endoscopic Submucosal Dissection (ESD) has witnessed slow adoption in Western countries in the past. This is due to the continued referral of patients for surgery or Endoscopic Mucosal Resection (EMR) procedures. Furthermore, ESD demands highly skilled and trained professionals.

Get Free Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/22897

Although the procedure is difficult to learn and the training is expensive, a small group of endoscopists in Western countries are becoming more interested. These endoscopists are working toward training in a Japanese centre to learn from experts. This change is expected to increase the adoption rate of endoscopic submucosal dissection over the coming years.

The global endoscopic submucosal dissection market was valued at US$ 200 Mn in 2018, and is expected to exhibit a healthy CAGR of 7.5% over the estimation period (2019–2029).

Company Profiles:

• Olympus Corporation
• Boston Scientific Corporation
• ERBE Elektromedizin GmbH
• FUJIFILM Medical Systems U.S.A., Inc
• Sumitomo Bakelite Co., Ltd
• Ovesco Endoscopy AG
• ZEON CORPORATION

Request for Methodology@ https://www.persistencemarketresearch.com/methodology/22897

Key Takeaways of Endoscopic Submucosal Dissection Market Study

• ESD is predominantly used for early stomach cancer. This is because the procedure is easy and well-studied for stomach cancer as compared to other gastric cancers. Colorectal cancers are the most complex for ESD procedures, primarily due to the large size of lesions and anatomy of the colon.
• Specialty clinics are expected to gain traction with the rising adoption of ESD in the Western hemisphere.
• Endoscopic submucosal dissection knives hold nearly 1/3 market share in the endoscopic submucosal dissection market, followed by tissue retractors. The knives segment is expected to continue holding a relatively similar share through 2029.
• East Asia, followed by Europe, are the most prominent regions in terms of revenue, due to higher prevalence and adoption of the endoscopic submucosal dissection procedure for gastric cancers.

“Although East Asia will continue to lead the global endoscopic submucosal dissection market, Western countries such as the U.S., Germany, and Brazil, along with the Oceania region, are expected to offer lucrative growth opportunities for players in the endoscopic submucosal dissection market. This is primarily due to rising adoption and increasing skilled professionals in these regions,” says a PMR analyst.

Access Full Report@ https://www.persistencemarketresearch.com/checkout/22897

Acquisitions and Partnerships are Key Strategies of Market Players

Manufacturers in the endoscopic submucosal dissection market are focusing on improving their product portfolios though the launch of new products. Key players are working toward getting new products approved by regulatory bodies and launching them at the earliest. Some manufacturers are also focused toward the development of other strategies, such as setting up training centers to drive product sales and gain market share, globally. Many endoscopists from Western countries opt for such training programs in East Asia to offer ESD procedures in their countries, such as in the U.S., Canada, and Brazil.

More Valuable Insights on Endoscopic Submucosal Dissection Market

Persistence Market Research offers a unique perspective and actionable insights on the endoscopic submucosal dissection market in its latest study, presenting historical demand assessment of 2014–2018 and projections for 2019–2029, on basis of product (knives, tissue retractors, grasps/clips, injection agents, and gastroscopes & colonoscopes), indication (esophageal cancer, stomach cancer, and colon cancer), and end user (hospitals, ambulatory surgical centers, and speciality clinics), across seven major regions.

About Us: 

PersistenceMarketResearch is an esteemed company with a reputation of serving clients across domains of information technology (IT), healthcare, and chemicals. Our analysts undertake painstaking primary and secondary research to provide a seamless report with a 360 degree perspective. Data is compared against rep/uted organizations, trustworthy databases, and international surveys for producing impeccable reports backed with graphical and statistical information.

Contact Us:

Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com

 

Corneal Implants Market: Global Key Players, Trends, Share, Industry Size, Growth, Opportunities, Forecast To 2031

 Corneal Implants Market 2022

The Global Corneal Implants Market is there to hit the exponential growth mark In Upcoming Years. This is the era of “online visibility”. The key stakeholders in enterprises are into an exploration of new-fangled opportunities concerning digital media, as online competition is there to rule for the next few years. With end-users turning out to be netizens, search engine optimization is of paramount importance. This would be the net-oriented trend going forward.

The use of corneal implants is gathering momentum around the world, owing to their proven efficacy for the correction of presbyopia by improving near and intermediate vision without any detriment to distant vision. Corneal implants are the most promising device used for refractive surgery, which brings about a change to improve the patient’s quality of life, besides being safe, effective, reversible, and minimally invasive. The introduction of newer material with enhanced biocompatibility along with advancements in related technology has amplified the success of corneal implants for visually impaired patients. Corneal implants have gained clinical significance on the basis of fewer risks associated with corneal inlay surgery as compared to intraocular surgery, faster visual recovery, and being more biomechanically stable.

Get Free Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/31340

The global corneal implants market was valued at US$ 18.5 Mn in 2018, and is expected to exhibit a high CAGR of 13% during the forecast period (2019–2029).

Company Profiles:

• CorneaGen (SightLife Surgical)
• Presbia PLC
• DIOPTEX Medizinprodukte Forschungs-, Entwicklungs- und Vertriebs GmbH

Request for Methodology@ https://www.persistencemarketresearch.com/methodology/31340

Key Takeaways of Corneal Implants Market Study

• The small aperture corneal implantable devices segment has emerged as the largest segment by implant type, representing 68% of revenue share in the corneal implants market. This is attributed to the use of biomaterial, which has holes to facilitate the diffusion of oxygen and nutrients through the cornea. This is the only corneal implant that is commercially available in the United States, Europe, Asia Pacific, and the Middle East.
• Ophthalmic clinics accounted for a major revenue share of 82%, owing to the larger proportion of inpatient corneal implant procedures and availability of skilled personnel to perform refractive surgeries on presbyopic patients.
• Cumulatively, North America and Europe hold more than 75% share of the global corneal implants market. Europe holds a slightly larger market share, and is expected to progress at an excellent CAGR of 14% during the forecast period.
• Increasing volume of refractive surgeries performed, rising prevalence of presbyopia, and high demand for corneal implants have contributed to the dominance of Europe in the global corneal implants market.

“The global market for corneal implants increases parallel with the fast-increasing presbyopic population. Wider array of approaches is being seen with corneal implants due to continuous advancements in technology,” says a PMR analyst.

Acquisition – Strategic Focus of Corneal implant Manufacturers

Various players in the corneal implant market are focusing on inorganic growth strategies such as acquisitions and partnerships. These activities have played a vital role in the expansion of businesses and increased customer base of market players. For example, in August 2016, Presbia PLC, an ophthalmic device company and leader in near-vision restoration, completed the acquisition of Neoptics AG, including its intellectual property portfolio. In March 2018, SightLife Surgical acquired AcuFocus, whose Kamra corneal inlay was the first to receive FDA approval, designed for the surgical correction of presbyopia. These winning strategies by leading players are also being followed by regional and local players.

Access Full Report@ https://www.persistencemarketresearch.com/checkout/31340

More Valuable Insights on Corneal Implants Market

Persistence Market Research brings a comprehensive research report on forecasted revenue growth at global, regional, and country levels, and provides an analysis of the latest industry trends in each of the sub-segments from 2014 to 2029. The global corneal implants market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the readers. The study provides compelling insights on the corneal implants market on basis of implant type (small aperture corneal implantable devices, corneal reshaping implantable devices, and refractive corneal implantable devices), end user (ophthalmic clinics, ambulatory surgical centers, and hospitals), and indication (presbyopia, hypermetropia, myopia, and astigmatism), across seven major regions.

About us: 

PersistenceMarketResearch is an esteemed company with a reputation of serving clients across domains of information technology (IT), healthcare, and chemicals. Our analysts undertake painstaking primary and secondary research to provide a seamless report with a 360 degree perspective. Data is compared against rep/uted organizations, trustworthy databases, and international surveys for producing impeccable reports backed with graphical and statistical information.

Contact us:

Persistence Market Research          
Address – 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com

 

Recombinant Cell Culture Supplements Market by Component, Application, Growth and Analysis – 2031

Recombinant Cell Culture Supplements Market 2022

The Global Recombinant Cell Culture Supplements Market is there to hit the exponential growth mark In Upcoming Years. This is the era of “online visibility”. The key stakeholders in enterprises are into an exploration of new-fangled opportunities concerning digital media, as online competition is there to rule for the next few years. With end-users turning out to be netizens, search engine optimization is of paramount importance. This would be the net-oriented trend going forward.

Cell culture supplements are the backbone of culturing methods and techniques in mammalian and microbial cell culture. Routinely performed cell-based assays and cell expansion processes require several growth factors to boost cell growth in the culture. Recombinant cell culture supplements serve an array of applications, such as stem cell research, drug discovery, oncology research, and regenerative medicine. Recombinant cell culture supplements and growth factors are used for culturing stem cells for expansion and differentiation into other cell types. Stem cell research is growing and adoption is increasing with time. Recombinant cell culture supplements such as albumin and transferrin are key components of mammalian cell culture. Increasing bioprocessing activities for production of novel biologics are likely to upswing the growth of the recombinant cell culture supplements market over the coming years.

Free Sample Copy Of Recombinant Cell Culture Supplements Market Report@ https://www.persistencemarketresearch.com/samples/31310

These days, a majority of supplements used in research and manufacturing are produced using recombinant technology. Recombinant supplements play an important role in gene and cell therapy. Cell therapy requires to grow the cells outside the human body, i.e. in-vitro, and, recombinant cell culture supplements are inevitable for such applications. Due to rapid development within the biopharmaceutical industry, recombinant cell culture supplements are anticipated to witness significant demand through 2031.

According to a latest report published by Persistence Market Research, the global recombinant cell culture supplements market was valued at US$ 441 Mn in 2020, and is predicted to witness an impressive CAGR of over 6% during the forecast period (2021 – 2031).

Company Profiles:

• Thermo Fisher Scientific
• Merck KGaA
• Lonza Group AG
• F. Hoffmann-La Roche AG
• Abcam PLC.
• Hi-Media Laboratories
• Becton, Dickinson and Company
• STEMCELL Technologies Inc.
• Fujifilm Corporation (Irvine Scientific)
• InVitria (Ventria Bioscience)
• Biocon
• Cell Sciences, Inc.

How About Revitalizing The Strategy-Oriented Funnel To Stay Ahead In The Recombinant Cell Culture Supplements Market? https://www.persistencemarketresearch.com/methodology/31310

 Key Takeaways from Recombinant Cell Culture Supplements Market Study       

• Recombinant growth factors are expected to contribute more than 1/3 of the revenue share in the market.
• By end user, biopharmaceutical companies will hold a major share of over 40% of the market. This sector is the most advancing as compared to other end users.
• By application, stem cell therapy is expected to hold the highest market share in 2020.
• North America holds over 1/3 of the global recombinant cell culture supplements market share.
• Key players are focused on expanding their product portfolios and expansion at regional levels through collaborations and acquisitions.
• The COVID-19 outbreak created a surge in demand for recombinant cell culture supplements, thus, accelerating growth of the market in 2020. Recombinant cell culture supplements were widely used in stem cell research and other cell-based assays performed for COVID-19 research.
• The market in China is projected to be the fastest-growing, and will expand at a CAGR above 9% through 2031.
• The U.S. market holds a big portion of the market revenue and accounts for more than 90% in North America.
• The market in the U.K. is expected to expand at a CAGR of around 7%, while that in China is pegged at over 9%.

“Increasing drug discovery and preference for recombinant technology for bio- production will upswing the global recombinant cell culture supplements market,” says an analyst of Persistence Market Research.

Planning To Introduce An Offbeat Product/Technology In The Recombinant Cell Culture Supplements Market? Go To “Purchase Now” To Have Our Recombinant Cell Culture Supplements Market Report! https://www.persistencemarketresearch.com/checkout/31310

Collaborations & Acquisitions Key Strategies amongst Market Players

Prominent players in the recombinant cell culture supplements market are firming their product ranges through acquisitions and reaching out to emerging markets. Increasing investments and manufacturing capacity expansion are expected to favour the growth the global market over the forecast period

• For instance, Cytiva (part of GE company), in 2018, announced the increase of its yearly production capacity of cell culture supplements and media.
• In July 2019, FUJIFILM Irvine Scientific announced the expansion of a new cell culture media manufacturing facility in Europe. FUJIFILM Irvine Scientific has already over 3 production facilities in the bio production sector, and gene and cell therapy.

Various players in the recombinant cell culture supplements market are focusing on growth strategies such as acquisitions and collaborations.

• One of the major acquisitions in the biopharmaceutical industry happened in 2015, when Merck KGaA acquired Sigma-Aldrich to strengthen and expand its cell culture product range.
• Thermo Fisher Scientific, in March 2020, signed an agreement with Janssen to co-develop novel cancer diagnostics.

What Does the Report Cover?

Persistence Market Research offers a unique perspective and actionable insights on the recombinant cell culture supplements market in its latest study, presenting historical demand assessment of 2016 – 2020 and projections for 2021 – 2031, on the basis of product (recombinant growth factors, recombinant insulin, recombinant albumin,  recombinant transferrin, recombinant trypsin, recombinant aprotinin, recombinant lysozyme, and others), application (stem cell therapy, gene therapy, bioprocess application, vaccine development, and others), source (animals, microorganisms, and humans), and end user (academic and research institutes, biopharmaceutical companies, cancer research centers, and contract research centers (CROs)), across seven key regions of the world.

About Us: 

PersistenceMarketResearch is an esteemed company with a reputation of serving clients across domains of information technology (IT), healthcare, and chemicals. Our analysts undertake painstaking primary and secondary research to provide a seamless report with a 360 degree perspective. Data is compared against rep/uted organizations, trustworthy databases, and international surveys for producing impeccable reports backed with graphical and statistical information.

Contact Us:

Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com

Global Tissue Dissociation Market Trends, Forecast, and Opportunity Assessment (2022-2031)

 Tissue Dissociation Market 2022

Tissue dissociation is a cell isolation process that is used to separate the human and animal tissues. Tissue dissociation process is performed with the help of isolation enzymes. Cell aggregates or distinctive cell types can be separated with the help of tissue dissociation process. The goal of a tissue dissociation process is to maximize the outcome of functionally viable, dissociated cell. This process is also used to adherent cell the culture in which cells is being cultured.

The global tissue dissociation market is expected to be driven by increasing focus on the research and development in pharmaceutical and healthcare industry. Increasing focus on development of monoclonal antibodies and customization of drug manufacturing process is also driving the market of tissue dissociation.

Get Free Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/20029

Increasing prevalence of chronic disease is also expected to drive the growth of dissociation market as the process is used for the development of advanced treatments. Increasing funding from various government bodies and private players is also expected to drive the growth of the tissue dissociation market.

Some of the market participants in the global tissue dissociation marker include, Miltenyi Biotec, Worthington Biochemical Corporation, Sigma-Aldrich Corporation, F. Hoffmann-La Roche AG, Becton Dickinson Biosciences, Thermo Fisher Scientific, VitaCyte LLC., Merck KGaA, and StemCell Technologies, Inc.

Tissue Dissociation Market: Segmentation

The global tissue dissociation market is segmented on the basis of tissue type, dissociation enzyme, end user and region.

basis of tissue type	Epithelial Tissue Connective Tissue
basis of dissociation enzyme	Collagenase Trypsin Elastase Hyaluronidase Papain Chymotrypsin Trypsin Inhibitor Animal Origin Free (AOF) Enzymes Other
basis of end user	Research Institutes Pharmaceutical Companies Biotechnology Companies Diagnostic Laboratories

Request for Table of Content@ https://www.persistencemarketresearch.com/toc/20029

The global tissue dissociation market is expected to show a significant growth over the forecast period. Increasing focus of pharmaceutical and biotechnology companies on development of monoclonal antibodies and customization of treatment is expected to drive the growth of the tissue dissociation market.

Advancement in the diagnostic procedure and increasing funding from the governments on the research related to the development of advanced methods of diagnostic process is also expected to drive the growth of tissue dissociation market. Connective tissue segment is expected to dominate the market over the forecast period as these tissues have better yield and help in development of high quality products.

Tissue dissociation has high demand in biotechnology companies and research institute as these end users are focusing on the development of novel therapies and targeted treatment option of lifestyle diseases such as, diabetes, cancer and other autoimmune disorders.

Geographically, the global tissue dissociation market can be segmented into regions: North America, Latin America, Europe, Asia Pacific (APAC) and Middle East & Africa (MEA). North America tissue dissociation market is dominating market and is expected to continue to dominate the global tissue dissociation market over the forecast period closely followed by the Europe.

High focus of North America and Europe on biotechnology related research and presence of some of the best research institutes in North America and Europe is expected to drive the growth of the global tissue dissociation market. Increasing focus of government bodies on funding the research and presence of top pharmaceutical companies in the region is also expected to fuel the growth of tissue dissociation market.

Asia Pacific region is expected to be fastest growing tissue dissociation market due to the increasing focus of pharmaceutical and biotechnology companies on research & development as well as growing healthcare infrastructure.

Access Full Report@ https://www.persistencemarketresearch.com/checkout/20029

Report Highlights:

• Detailed overview of parent market
• Changing market dynamics of the industry
• In-depth market segmentation
• Historical, current and projected market size in terms of value
• Recent industry trends and developments
• Competitive landscape
• Strategies of key players and product offerings
• Potential and niche segments/regions exhibiting promising growth
• A neutral perspective towards market performance
• Must-have information for market players to sustain and enhance their market footprint

About Us:

PersistenceMarketResearch is an esteemed company with a reputation of serving clients across domains of information technology (IT), healthcare, and chemicals. Our analysts undertake painstaking primary and secondary research to provide a seamless report with a 360 degree perspective. Data is compared against rep/uted organizations, trustworthy databases, and international surveys for producing impeccable reports backed with graphical and statistical information.

Contact Us:

Persistence Market Research
USA

Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353

Sales – sales@persistencemarketresearch.com

 

Swine Diagnostic Testing Market by Type, Share, Growth and Analysis – 2031

 Swine Diagnostic Testing Market 2022

The global Swine Diagnostic Testing Market is there to witness an irrevocable In Upcoming Years. Innovation in the form of digital tools is the buzzword all across. Even though it’s the youth engaging in digital and social platforms, the geriatric population could get benefited by engaging the services therein. Thus, the exponential influx of e-business, online consultations, and booking, door-step delivery are likely to run through the enterprise going forward.

Swine diagnostic testing is extremely important for pork breeders to keep adverse effects on production and minimum economic losses. Hog cholera is highly contagious and most frequent disease affecting pigs. Swine diseases is the major factor causing loss in modern day pig production. Swine industry is facing major challenge of infectious diseases.

Pandemic infections such as swine flu outbreaks in 2009 reinforced the need for development of rapid and efficient diagnostic testing methods for swine diseases. There is no perfect testing available for swine infectious diseases, however, selection of best test is done based on  multiple factors.

Get Free Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/16954

Some of the players operating in global swine diagnostic testing market are Elanco (Eli Lilly & Co.), Merck Sharp & Dohme Corp. (Merck & Co. Inc.), Qiagen N.V. etc.

To provide a good quality meat it is necessary to keep a regular check on animals, which is expected to favor global swine diagnostic testing market. Penetration of easy to use molecular diagnostic testing kits for swine infectious diseases is an important factor pushing the market growth. Over the next few years considerable increase in pork meat production is expected across the world.

According to USDA Foreign Agricultural services, pork meat consumption accounted for 40.1% of overall meat consumption in the world in 2015. Some of the commercially available swine diagnostic kits are mericon Pig Kit, pigtype Toxoplasma Ab kit (Qiagen N.V.), etc.

Growing consumption of pork meat is expected to be the prime factor driving the growth of global swine diagnostic testing market. According to National Pork Producers Council, estimated the pork production to reach US$ 23.4 Bn in 2016. Infectious disease outbreaks in and incidence of zoonotic diseases and advancement in animal diagnostic industry are some other factors driving growth of swine diagnostic testing market.

Performance of swine diagnostics market is primarily determined by prevalence of infectious food animal diseases across the globe. However, the global market for swine diagnostic testing is expected to be deter by limited number of products available on the market.

Request for Table of Content@ https://www.persistencemarketresearch.com/toc/16954

The global market for perfusion bioreactors is segmented on basis of product type, sample type, end user and geography:

Product Type

• Immunoassays (ELISA) Kits
• PCR Kits
• Others

Sample Type

• Nasal Swab
• Oral Fluids
• Tissue Samples
• Blood
• Bronchoalveolar fluid
• Cervical Swab and Semen
• Urine and Feces

End User

• Veterinary Hospitals
• Veterinary Clinics

Based on product type, immunoassay kits segment is expected to contribute maximum share in global swine diagnostic testing market due to easy availability of test reagents. Newly introduced PCR assay kits are gaining popularity in mature markets such as the U.S. and Europe owing to ease-of-use. By sample type, oral fluids and blood samples are most common practices for swine diagnostic testing, across the globe.

On the basis of regional presence, global swine diagnostic testing market is segmented into five key regions viz. North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America is expected to lead the global market primarily due to growing pork meat consumption and pork export.

According to United States International Trade Commission 10% of global pork production in 2013. Europe is expected to be the second largest market for swine diagnostic testing market. Asia pacific swine diagnostic testing market is expected to witness considerable growth over the forecast period due to increasing demand for diagnostic test kits in animal health industries of India and China owing to growing pork meat consumption. According to USDA data, China witnessed highest pork meat consumption of 90.1 lbs per person in 2015, which is approximately 36% higher than that in the U.S.

Access Full Report@ https://www.persistencemarketresearch.com/checkout/16954

Report Highlights:

• Detailed overview of parent market
• Changing market dynamics of the industry
• In-depth market segmentation
• Historical, current and projected market size in terms of value
• Recent industry trends and developments
• Competitive landscape
• Strategies of key players and product offerings
• Potential and niche segments/regions exhibiting promising growth
• A neutral perspective towards market performance
• Must-have information for market players to sustain and enhance their market footprint

About Us:

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.

Contact Us:

Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com

Noninvasive Ventilation Masks And Circuits Market by Component, Application, Growth and Analysis – 2030

 Noninvasive Ventilation Masks And Circuits Market 2022

The Global Noninvasive Ventilation Masks And Circuits Market ought to witness an explicit In Upcoming Years. With geographical barriers out of sight, track-and-trace programs are on the verge to reach their zenith in the timespan mentioned above. This could be credited to OEMs trying to reach out to the end-users remotely through virtual setups. Plus, people are getting a broader choice regarding choosing the experts. This holds for preventive as well as curative measures. The trend is certain to embark upon massive transience in the years to come.

Adoption of non-invasive ventilation masks and circuits will increase due to large procedural benefits that they offer - masks provide an optimal fit, along with minimizing pressure and leakage points. At present, there is increased demand for non-invasive ventilation masks and circuits due to the growing incidence of coronavirus disease, especially among the elderly population and those suffering from long-term chronic respiratory disorders, which provides an opportunity for manufactures to innovate and increase their product sales.

Get Free Sample Of Noninvasive Ventilation Masks And Circuits Market Report@ https://www.persistencemarketresearch.com/samples/31545

Increasing collaborations and R&D investments toward developing disposable and reusable consumables, along with a refined distribution network are expected to boost the growth of the non-invasive ventilation masks and circuits market. The market was valued at US$ 2.4 Bn in 2019, and is expected to progress at a CAGR of more than 9% during the forecast period (2020–2030).

Key Takeaways from Non-invasive Ventilation Masks and Circuits Market Study

• Based on product, due to superior product efficiency, non-invasive ventilation disposable and reusable masks together generated over 82% market value share in the global non-invasive ventilation masks and circuits market in 2019.
• Various product launches by key players along with technological advancements are expected to aid market growth over the coming period. For instance, in 2019, Hamilton added to the vented and non-vented adapters for single-use masks and the non-vented adapters for reusable masks.
• In terms of end user, hospitals hold over 55% value share in the global non-invasive ventilation masks and circuits market, due to increasing prevalence of respiratory disorders and the current outbreak of COVID-19. As a result, the use of non-invasive masks and circuits is increasing across emerging countries such as China, Brazil, and India.
• North America has captured over half market value share, and is expected to be the most lucrative region in the global non-invasive ventilation masks and circuits market during the forecast period. The market in the region is characterized by the higher prevalence and diagnosis rates of infectious diseases and more awareness regarding advanced non-invasive ventilation masks & circuits.

“Increasing adoption of non-invasive ventilation masks and circuits due to their large procedural benefits and availability of low-end product in most countries are some of the factors expected to aid the growth of the global non-invasive ventilation masks and circuits market in the coming years,” says a PMR analyst.

Switch Over To The “Methodology” Tab@ https://www.persistencemarketresearch.com/methodology/31545

Collaborations & Launching of New Products – An Imperative Strategy for Market Players

Market introduction of new, innovative products and collaboration with various larger as well as regional market players are some of the major factors responsible for intense competition among players in the global non-invasive ventilation masks and circuits market. Most companies in this market space are small and medium business enterprises, which limits the competition of market players to specific regions.

What else is in the report?

Persistence Market Research offers a unique perspective and actionable insights on the non-invasive ventilation masks and circuits market, in its latest study, presenting historical demand assessment of 2015–2019 and projections for 2020–2030, based on product (non-invasive ventilation masks, non-invasive ventilation circuits), application (anesthesia, respiratory dysfunction, chronic obstructive pulmonary diseases, pneumonia, others), and end user (hospitals, ambulatory surgical centers, critical care, neonatal intensive care, homecare settings), across seven key regions.

Buy Now@ https://www.persistencemarketresearch.com/checkout/31545

Report Highlights:

• Detailed overview of parent market
• Changing market dynamics of the industry
• In-depth market segmentation
• Historical, current and projected market size in terms of value
• Recent industry trends and developments
• Competitive landscape
• Strategies of key players and product offerings
• Potential and niche segments/regions exhibiting promising growth
• A neutral perspective towards market performance
• Must-have information for market players to sustain and enhance their market footprint

About us: 

PersistenceMarketResearch is an esteemed company with a reputation of serving clients across domains of information technology (IT), healthcare, and chemicals. Our analysts undertake painstaking primary and secondary research to provide a seamless report with a 360 degree perspective. Data is compared against rep/uted organizations, trustworthy databases, and international surveys for producing impeccable reports backed with graphical and statistical information.

Contact us:

Persistence Market Research          
Address – 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com